|
RBMS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.07470000000476E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.618200E-04 |
| Normal-vs-Stage2 |
1.424590E-01 |
| Normal-vs-Stage3 |
4.145200E-01 |
| Normal-vs-Stage4 |
8.437200E-01 |
| Stage1-vs-Stage2 |
5.808800E-01 |
| Stage1-vs-Stage3 |
1.953950E-01 |
| Stage1-vs-Stage4 |
2.504400E-01 |
| Stage2-vs-Stage3 |
5.986400E-01 |
| Stage2-vs-Stage4 |
4.751600E-01 |
| Stage3-vs-Stage4 |
7.733000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.562000E-04 |
| Normal-vs-AfricanAmerican |
2.064100E-03 |
| Normal-vs-Asian |
9.720600E-01 |
| Caucasian-vs-AfricanAmerican |
5.000600E-01 |
| Caucasian-vs-Asian |
3.578000E-01 |
| AfricanAmerican-vs-Asian |
2.661800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.61059999999847E-05 |
| Normal-vs-Female |
1.624210E-02 |
| Male-vs-Female |
6.768800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.456580E-01 |
| Normal-vs-Extreme_Weight |
2.971800E-02 |
| Normal-vs-Obese |
7.369500E-04 |
| Normal-vs-Extreme_Obese |
7.947200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.048800E-01 |
| Normal_Weight-vs-Obese |
1.554050E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.661600E-01 |
| Extreme_Weight-vs-Obese |
1.561570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.630200E-01 |
| Obese-vs-Extreme_Obese |
1.620960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.407700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.30949999999075E-06 |
| Normal-vs-Age(61-80Yrs) |
3.555500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.530000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.790600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.729610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.367830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.224500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.458100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.824200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.63059998626159E-09 |
| Normal-VS-Type2 PRCC |
1.763360E-01 |
| Normal-VS-KIRP CIMP |
2.972000E-01 |
| Normal-VS-Unclassified PRCC |
4.738700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.87340040650008E-10 |
| Type1 PRCC-VS-KIRP CIMP |
3.951000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.399800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.642100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.221700E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
5.030800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.233400E-01 |
| Normal-vs-N1 |
7.306100E-02 |
| Normal-vs-N2 |
7.593200E-01 |
| N0-vs-N1 |
1.863580E-01 |
| N0-vs-N2 |
8.580400E-01 |
| N1-vs-N2 |
1.537010E-01 |
|
|
